Gunaretnam (Guna) Rajagopal is a distinguished scientist and expert in computational sciences, drug discovery, cyber-infrastructure deployment, and translational research. With an educational background in physics and theoretical high energy physics, he holds a PhD in Theoretical & Computational Condensed Matter Physics from the Georgia Institute of Technology. Dr. Rajagopal has vast experience leading multi-disciplinary teams of scientists, including physicists, mathematicians, computational biologists, statisticians, bioinformatics specialists, and wet lab experts.

Dr. Rajagopal is the VP - Global Head of Computational Sciences at Janssen, Pharmaceutical Companies of Johnson and Johnson, leading a team that brings together cutting-edge bioinformatics, machine learning, and computational modeling and simulation techniques to generate, evaluate and translate biomedical data into drug targets. He has been engaged in several projects in collaboration with researchers across the globe aimed at understanding genetic perturbations that lead to diseases and developing insights gained to drug discovery.

Prior to his work at Janssen, Dr. Rajagopal served as the VP & CIO- Research, Bioinformatics & External Innovation at Janssen, where he developed/deployed cyber-infrastructure to support the needs of the research community at Janssen R&D. Previously, he has served as an adjunct professor of radiation oncology at Rutgers Cancer Institute of New Jersey and is a former member at Institute for Advanced Study, Princeton. Dr. Rajagopal has also held the positions of Executive Director (Bioinformatics) at Rutgers Cancer Institute of New Jersey, Executive Director at Bioinformatics Institute, Singapore, Assistant Director of Research (Theory of Condensed Matter Group) at Cavendish Laboratory, University of Cambridge, and Fellow and Director of Studies (Physics) at Jesus College, Cambridge.